pimonidazole has been researched along with hoe 33342 in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dewhirst, MW; Greenberg, CS; Haroon, ZA; Raleigh, JA | 1 |
| Bernsen, HJ; Hodgkiss, RJ; Peters, JP; Raleigh, JA; Rijken, PF; van der Kogel, AJ | 1 |
| Bussink, J; Denekamp, J; Ljungkvist, AS; Raleigh, JA; Rijken, PF; Van Der Kogel, AJ | 1 |
| Banáth, JP; Luo, CM; Olive, PL | 1 |
| Burgman, P; Burnazi, E; Cai, S; Finn, RD; Humm, JL; Lewis, JS; Ling, CC; O'Donoghue, JA; Pugachev, A; Ruan, S; Smith-Jones, P; Welch, MJ; Wen, B; Zanzonico, P | 1 |
| Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S | 1 |
| Begg, AC; Bussink, J; Kaanders, JH; Ljungkvist, AS; Raleigh, JA; Rijken, PF; van der Kogel, AJ | 1 |
| Boerman, OC; Bussink, J; Kaanders, JH; Peters, JP; Rijken, PF; Troost, EG; van der Kogel, AJ; van Eerd, J | 1 |
| Down, JD; Mauch, P; Parmar, K; Sackstein, R; Vergilio, JA | 1 |
| Baumann, M; Meyer, S; Mueller-Klieser, W; Quennet, V; Shakirin, G; Walenta, S; Yaromina, A; Zips, D | 1 |
| An, H; Engenhart-Cabillic, R; Eul, BG; Fokas, E; Hänze, J; Heverhagen, JT; Kamlah, F; Keil, B; Lang, N; Rose, F | 1 |
| Astner, ST; Bayer, C; Maftei, CA; Shi, K; Vaupel, P | 1 |
| Baker, LC; Boult, JK; Burrell, JS; Halliday, J; Jamin, Y; Robinson, SP; Ryan, AJ; Walker-Samuel, S; Waterton, JC | 1 |
| Baumann, M; Mönnich, D; Thorwarth, D; Wack, LJ; Yaromina, A; Zips, D | 1 |
14 other study(ies) available for pimonidazole and hoe 33342
| Article | Year |
|---|---|
Early wound healing exhibits cytokine surge without evidence of hypoxia.
Topics: Animals; Benzimidazoles; Cell Division; Cell Hypoxia; Cytokines; DNA Adducts; Endothelial Growth Factors; Female; Fluorescent Dyes; Ki-67 Antigen; Lymphokines; Microscopy, Fluorescence; Neovascularization, Physiologic; Nitroimidazoles; Rats; Rats, Inbred F344; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Wound Healing | 2000 |
Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.
Topics: Animals; Benzimidazoles; Cell Hypoxia; Fluorescent Dyes; Glioma; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Radiation-Sensitizing Agents; Regional Blood Flow; Theophylline; Transplantation, Heterologous | 2000 |
Changes in tumor hypoxia measured with a double hypoxic marker technique.
Topics: Animals; Benzimidazoles; Biomarkers; Carbon Dioxide; Carcinoma, Squamous Cell; Cell Hypoxia; Endothelium, Vascular; Fluorescent Dyes; Mice; Mice, Inbred BALB C; Mice, Nude; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2000 |
Local hypoxia is produced at sites of intratumour injection.
Topics: Animals; Benzimidazoles; Carcinoma, Squamous Cell; Cell Hypoxia; Comet Assay; DNA Damage; Humans; Injections; Mice; Nitroimidazoles; Radiation-Sensitizing Agents | 2002 |
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent mic
Topics: Animals; Autoradiography; Benzimidazoles; Cell Hypoxia; Coordination Complexes; Fluorodeoxyglucose F18; Humans; Immunohistochemistry; Male; Microscopy, Fluorescence; Misonidazole; Neoplasms; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Rats; Rats, Nude; Thiosemicarbazones; Transplantation, Heterologous | 2005 |
Dependence of FDG uptake on tumor microenvironment.
Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals | 2005 |
Hypoxic cell turnover in different solid tumor lines.
Topics: Animals; Benzimidazoles; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Coloring Agents; Half-Life; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Nitroimidazoles; Time Factors | 2005 |
Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines.
Topics: Animals; Antigens, Neoplasm; Benzimidazoles; Carbonic Anhydrase IX; Carbonic Anhydrases; Cell Hypoxia; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles | 2005 |
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.
Topics: Animals; Benzimidazoles; Bone Marrow Cells; Cell Differentiation; Hematopoietic Stem Cells; Hematopoietic System; Hypoxia; Mice; Mice, Inbred C57BL; Nitroimidazoles; Oxygen; Perfusion; Stem Cells; Tirapazamine; Triazines | 2007 |
Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts.
Topics: Animals; Benzimidazoles; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Fluorescent Dyes; Glucose; Humans; Hypoxia; Lactic Acid; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Transplantation, Heterologous | 2009 |
Irradiation-dependent effects on tumor perfusion and endogenous and exogenous hypoxia markers in an A549 xenograft model.
Topics: Adenocarcinoma; Animals; Apoptosis; Benzimidazoles; Biomarkers; Caspase 3; Cell Hypoxia; Contrast Media; Gadolinium; Glucose Transporter Type 1; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microscopy, Fluorescence; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Time Factors; Transplantation, Heterologous | 2010 |
Quantitative assessment of hypoxia subtypes in microcirculatory supply units of malignant tumors using (immuno-)fluorescence techniques.
Topics: Benzimidazoles; Cell Hypoxia; Cell Line, Tumor; Diffusion; Humans; Microcirculation; Microscopy, Fluorescence; Microvessels; Neoplasms; Nitroimidazoles; Perfusion Imaging; Prognosis; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 2011 |
Evaluation of novel combined carbogen USPIO (CUSPIO) imaging biomarkers in assessing the antiangiogenic effects of cediranib (AZD2171) in rat C6 gliomas.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Biomarkers, Tumor; Contrast Media; Dextrans; Fluorescent Dyes; Glioma; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Nitroimidazoles; Quinazolines; Radiation-Sensitizing Agents; Rats; Rats, Nude; Tumor Cells, Cultured | 2012 |
Correlation of FMISO simulations with pimonidazole-stained tumor xenografts: A question of O2 consumption?
Topics: Animals; Benzimidazoles; Carcinoma, Squamous Cell; Cell Line, Tumor; Computer Simulation; Feasibility Studies; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Hypoxia; Mice, Nude; Misonidazole; Models, Biological; Neoplasm Transplantation; Nitroimidazoles; Oxygen Consumption; Platelet Endothelial Cell Adhesion Molecule-1; Tumor Microenvironment | 2016 |